Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

Poor Healthcare Policies and Infrastructure, But India’s Pharma Market Continues to Boom

Published: Tuesday, August 21, 2012
Last Updated: Tuesday, August 21, 2012
Bookmark and Share
Country’s pharmaceutical industry continue to expand rapidly in the coming years.

India has numerous healthcare problems, ranging from inadequate policy monitoring to the widespread lack of health insurance, but a potentially huge, unsaturated market will see the country’s pharmaceutical industry continue to expand rapidly in the coming years, predicts the latest study by market analysts GlobalData.

According to the new report, India’s pharmaceutical market had a 2011 valuation of $15 billion in 2011, but this is expected to rocket to $54 billion by 2020, climbing at a Compound Annual Growth Rate (CAGR) of 15.4% during this period.

A substantial portion of India’s pharmaceutical industry growth can be attributed to its export sector, which had a 2010 value of $8.8 billion - 40% of the country’s pharmaceutical industry turnover.

India’s generic drug sector is by far the dominant force in the country’s pharmaceutical industry, accounting for approximately 95% of revenue.

Furthermore, 80% of these generics were produced by domestic firms.

GlobalData’s report states that this already booming market has the potential for huge further expansion thanks to India’s considerable population and high number of leading drugs going off-patent every year.

But despite this pharmaceutical prosperity, India faces several sizeable healthcare challenges.

Spending on healthcare increased gradually to 4.2% of Gross Domestic Product (GDP) in 2010, but remained below that of other emerging economies such as Brazil, Russia, China and South Africa.

India’s healthcare infrastructure is also insufficiently prepared to meet growing demand. Currently there are only 0.9 beds per 1,000 people, in addition to a lack of qualified staff and poor management.

The country’s poor healthcare infrastructure has corresponding problems. Health coverage is low across the country, with 80% of the population not covered by any form of insurance in 2010.

The relatively low level of urbanization in India is a major contributing factor to this low insured population figure as healthcare infrastructure in rural areas is particularly inadequate.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Fall from Grace of Peregrine Pharmaceuticals
On September 24, 2012, the company announced the discovery of ‘major data discrepancies’ between reported results and patient treatment code assignments.
Wednesday, October 17, 2012
Aplastic Anemia Patients in Need of New Treatment Options
New study explores the failings of current treatment options for aplastic anemia.
Friday, February 24, 2012
Scientific News
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Hyperstable Peptides for 'On-Demand' Drugs
These small molecules can fold into different conformations that could allow for greater flexibility in precision drug design
Drug Leads Identified to Combat Heart Disease
Using three supercomputers, researchers surveyed protein structures through accelerated molecular dynamics.
Accelerating the Path to Molecules for Medicine
Researchers convert carbon-hydrogen bonds into nitriles - converting organic molecules into components of medicines.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos